AGP Executive Report
Last update: 7 hours agoIraq Health Ministry: Iraq’s Health Ministry says it will verify medicine stocks at health institutions and target “negligence” in medicine supply, as pressure on healthcare systems grows. Pharma Access: Sweden’s Newbury Pharmaceuticals signed a 10-year exclusivity deal granting rights to register and market 40 injectable and acute-care medicine products in Iraq, pending import licensing. Medicine Costs & Shortages (regional spillover): Reports from Iran describe medicine prices soaring—some tripling—and treatments becoming harder to find as sanctions and blockades squeeze pharmaceutical imports; Iraqi patients and supply chains may feel knock-on effects. Aviation & Health Access: Iraq suspended Iranian flights but is seeking US Treasury exemptions to resume limited services via Najaf, with lawmakers warning disruptions could affect travel for education and medical needs. Security & Health Context: In Maysan, three young men were killed in separate incidents, underscoring ongoing local instability that can strain emergency care and public health response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.